IMCD to Showcase Advanced Pharma and Nutra Innovations at FCE Pharma 2025
IMCD Group, a global leader in the distribution and formulation of specialty chemicals and ingredients, is set to make a prominent appearance at FCE Pharma 2025, Latin America’s premier trade fair for the pharmaceutical industry. The event is scheduled to take place from June 10 to June 12, 2025, in São Paulo, Brazil, and IMCD will use this platform to demonstrate its latest innovations and commitment to driving pharmaceutical and nutraceutical advancements in the region.
In recent years, IMCD has strategically expanded its footprint throughout Latin America, reinforcing its presence in key markets such as Argentina, Uruguay, Chile, Mexico, the Caribbean, Central America, Colombia, Peru, and Ecuador. This expansion includes the acquisition of influential companies like the Blumos Group, enhancing capabilities in both technical support and commercial reach. IMCD’s comprehensive product portfolio addresses a broad range of industries, including active pharmaceutical ingredients (APIs), excipients, nutraceuticals, agrochemicals, and veterinary medicine. Particularly notable is global leadership in the excipients sector, a crucial component in pharmaceutical formulation.
One of IMCD’s key strategies is to help accelerate product development timelines for its clients through innovative formulation solutions. The company operates a state-of-the-art applications laboratory in Valinhos, São Paulo, which serves as a hub for research and development focused on pharmaceutical, nutraceutical, and veterinary products. Through this facility, IMCD offers expert technical support to partners across Brazil and the wider Latin American region, playing a pivotal role in delivering market-ready, scientifically backed solutions.
At FCE Pharma 2025, will unveil a range of novel prototypes and formulations that illustrate the company’s emphasis on consumer convenience, targeted health benefits, and functional innovation. These product concepts, developed by IMCD’s multidisciplinary team of experts, include:
- On-the-Go Vitamin Gel: A multivitamin gel conveniently packaged in oral stick form, containing a blend of vitamins including B12, B2, B5, D, A, and E. Designed for busy lifestyles, this formulation supports general wellness with an easy-to-use delivery system.
- Beauty Fresh Drink: A functional beverage enriched with collagen and coenzyme Q10, this formulation aims to improve skin elasticity and firmness, responding to growing consumer demand for beauty-from-within products.
- Heart Health Sachet: A water-dispersible sachet that combines key ingredients such as coenzyme Q10, vitamin B12, and cholesterol-lowering compounds. It targets cardiovascular health and offers consumers a practical, on-the-go solution for heart support.
- Vitamin C + Iron XR Tablet: A cutting-edge extended-release tablet that synergistically delivers vitamin C and microencapsulated iron, improving bioavailability and minimizing gastrointestinal side effects, thereby enhancing patient adherence.
- Lip Moisturiser with Dexpanthenol: Designed to nourish and protect, this lip care product includes dexpanthenol for a soothing, moisturizing effect. It responds to consumer preferences for dermatologically driven skincare.
Patrick Thuring, Business Director Latin America and Head of Pharmaceuticals Brazil at IMCD, emphasized the company’s holistic and customer-centric approach: “IMCD is committed to delivering excellence through innovative solutions that respond directly to our clients’ most pressing challenges. Our technical expertise, combined with our extensive and complementary portfolio, positions us as a strategic partner. With our laboratory services and supply chain capabilities, we act as an extension of our clients’ own operations.”
IMCD’s participation in FCE Pharma 2025 not only highlights the company’s robust product development pipeline but also underscores its role in shaping the pharmaceutical and nutraceutical landscapes in Latin America. The company’s involvement in this key industry event reinforces its dedication to fostering collaboration, enabling knowledge exchange, and promoting the adoption of next-generation formulations.
Beyond showcasing product innovations, IMCD’s presence at FCE Pharma signifies a broader vision for industry evolution. By combining its distribution strength with cutting-edge formulation capabilities and a deep understanding of market needs, IMCD aims to empower pharmaceutical companies to bring safer, more effective, and consumer-friendly products to market faster.
Moreover, the company’s ongoing investment in professional development through programs like the IMCD Academy ensures that its teams remain at the forefront of scientific and technical excellence. These initiatives, coupled with the strategic expansion in Latin America, reinforce IMCD’s commitment to being not just a supplier, but a collaborative partner in innovation.
With more than 140 years of global expertise, IMCD continues to set the standard in specialty chemical distribution. Its evolving presence in Latin America and proactive engagement at events like FCE Pharma 2025 exemplify how the company leverages its global strengths to meet local market demands. As IMCD looks ahead, it remains focused on sustainability, performance, and the continual elevation of industry benchmarks in health and wellness.
In conclusion, IMCD’s participation at FCE Pharma 2025 is poised to leave a lasting impression, offering attendees valuable insights into emerging trends, formulation technologies, and integrated service solutions. Through its comprehensive approach to innovation and partnership, IMCD reaffirms its leadership in shaping the future of pharmaceuticals and nutraceuticals in Latin America and beyond.
